Get the Stockscreener App
8.05
1.71%
-0.14
After Hours:
7.91
-0.14
-1.74%
Aurinia Pharmaceuticals Inc Stock (AUPH) Forecast
The Aurinia Pharmaceuticals Inc (AUPH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.42, representing a +79.08% increase from the current price of $8.05. The highest analyst price target is $16.00, and the lowest is $12.83.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AUPH Price Target
Average 15.60
(+93.84% Upside)
Is Aurinia Pharmaceuticals Inc (AUPH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.29 | Neutral |
| STOCH(9,6) | 26.58 | Neutral |
| STOCHRSI(14) | 4.4153 | Buy |
| MACD(12,26) | 0.0112 | Sell |
| ADX(14) | 12.65 | Neutral |
| William %R | -80.00 | Neutral |
| CCI(14) | -102.46 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.324
Sell
|
8.2255
Sell
|
| MA20 |
8.2795
Sell
|
8.2357
Sell
|
| MA50 |
8.1124
Sell
|
8.2009
Sell
|
| MA100 |
8.3986
Sell
|
8.0597
Sell
|
| MA200 |
7.3971
Buy
|
7.7096
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, AUPH could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on AUPH, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.29 indicates that AUPH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.58 indicates that AUPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.4153 indicates that AUPH is oversold. This suggests that AUPH price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.65 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -102.46 indicates that AUPH is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term AUPH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aurinia Pharmaceuticals Inc financial reports and earnings history, Aurinia Pharmaceuticals Inc (AUPH) stock could reach $4.7235 by 2030, $8.8131 by 2040 and $7.825 by 2050. See the projected annual prices until 2050 of the Aurinia Pharmaceuticals Inc stock below:
- Aurinia Pharmaceuticals Inc (AUPH) is expected to reach an average price of $7.4181 in 2035, with a high prediction of $8.2981 and a low estimate of $5.1848. This indicates an $-7.85% rise from the last recorded price of $8.05.
- Aurinia Pharmaceuticals Inc (AUPH) stock is projected to chart a bullish course in 2040, with an average price target of $8.5631, representing an $6.37% surge from its current level. The forecast ranges from a conservative $6.5097 to a sky-high $8.8131.
- Our analysts predict Aurinia Pharmaceuticals Inc (AUPH) to jump -54.15% by 2045, soaring from $2.9914 to an average price of $3.6911, potentially reaching $4.2287. While $2.9914 is the low estimate, the potential upside is significant.
- Aurinia Pharmaceuticals Inc (AUPH) stock is expected to climb by 2050, reaching an average of $7.2807, a $-9.56% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.825 and $5.2407, respectively, highlighting the market's uncertainty.
Aurinia Pharmaceuticals Inc Stock (AUPH) Year by Year Forecast
Aurinia Pharmaceuticals Inc Stock (AUPH) Price Forecast for 2025
Aurinia Pharmaceuticals Inc Stock (AUPH) is expected to reach an average price of $14.87 in 2025, with a high prediction of $20.92 and a low estimate of $8.8284. This indicates an +84.78% rise from the last recorded price of $8.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $15.47 | $12.83 | $16.00 | +92.20% |
| June, 2025 | $16.16 | $14.52 | $17.72 | +100.80% |
| July, 2025 | $15.70 | $13.57 | $16.74 | +94.99% |
| August, 2025 | $13.89 | $13.81 | $15.75 | +72.54% |
| September, 2025 | $13.68 | $11.81 | $15.78 | +69.96% |
| October, 2025 | $12.72 | $12.10 | $14.04 | +58.07% |
| November, 2025 | $13.75 | $12.30 | $14.58 | +70.77% |
| December, 2025 | $14.70 | $13.04 | $15.31 | +82.61% |
Aurinia Pharmaceuticals Inc Stock (AUPH) Price Forecast for 2026
The predicted value for Aurinia Pharmaceuticals Inc (AUPH) in 2026 is set at an average of $15.99. Estimates vary from a peak of $23.23 to a trough of $8.7572, indicating an +98.67% surge from the present price of $8.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $13.60 | $11.85 | $14.73 | +68.97% |
| February, 2026 | $12.03 | $11.83 | $14.66 | +49.50% |
| March, 2026 | $12.34 | $11.68 | $13.84 | +53.25% |
| April, 2026 | $14.98 | $12.54 | $19.53 | +86.08% |
| May, 2026 | $12.67 | $11.04 | $14.98 | +57.42% |
| June, 2026 | $11.83 | $11.05 | $12.72 | +47.01% |
| July, 2026 | $10.96 | $8.7572 | $12.86 | +36.11% |
| August, 2026 | $11.90 | $10.89 | $14.04 | +47.82% |
| September, 2026 | $11.62 | $10.79 | $13.88 | +44.38% |
| October, 2026 | $13.46 | $9.8136 | $13.80 | +67.26% |
| November, 2026 | $15.33 | $11.67 | $17.85 | +90.40% |
| December, 2026 | $21.11 | $15.41 | $23.23 | +162.30% |
Aurinia Pharmaceuticals Inc Stock (AUPH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aurinia Pharmaceuticals Inc (AUPH) is $19.90, with a high forecast of $33.02 and a low forecast of $6.7789. This indicates an +147.23% increase from the last price of $8.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $23.49 | $16.70 | $23.49 | +191.83% |
| February, 2027 | $27.52 | $25.29 | $33.02 | +241.92% |
| March, 2027 | $20.04 | $16.36 | $23.61 | +148.91% |
| April, 2027 | $18.77 | $16.91 | $23.51 | +133.16% |
| May, 2027 | $16.68 | $12.68 | $18.99 | +107.23% |
| June, 2027 | $9.645 | $9.015 | $19.54 | +19.81% |
| July, 2027 | $11.45 | $8.9761 | $12.07 | +42.20% |
| August, 2027 | $9.8896 | $9.7896 | $12.18 | +22.85% |
| September, 2027 | $11.00 | $7.9314 | $11.46 | +36.68% |
| October, 2027 | $9.7048 | $8.2548 | $12.49 | +20.56% |
| November, 2027 | $11.47 | $8.8659 | $11.68 | +42.45% |
| December, 2027 | $7.5001 | $6.7789 | $11.48 | -6.83% |
Aurinia Pharmaceuticals Inc Stock (AUPH) Price Forecast for 2028
In 2028, Aurinia Pharmaceuticals Inc (AUPH) is projected to reach an average price of $7.1967, with a high projection of $11.23 and a low estimate of $3.1634. This indicates an -10.60% fall from the last price of $8.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.3024 | $5.9424 | $7.8256 | -21.71% |
| February, 2028 | $6.6047 | $5.3629 | $6.9747 | -17.95% |
| March, 2028 | $7.2176 | $5.7314 | $7.607 | -10.34% |
| April, 2028 | $3.9699 | $3.5799 | $7.4332 | -50.68% |
| May, 2028 | $3.6228 | $3.4928 | $4.3311 | -55.00% |
| June, 2028 | $7.4251 | $3.1634 | $8.6445 | -7.76% |
| July, 2028 | $7.4974 | $7.2174 | $8.7957 | -6.86% |
| August, 2028 | $7.8903 | $6.648 | $9.5303 | -1.98% |
| September, 2028 | $8.9626 | $7.6709 | $10.84 | +11.34% |
| October, 2028 | $10.66 | $8.3032 | $11.23 | +32.48% |
| November, 2028 | $8.6479 | $7.9479 | $10.75 | +7.43% |
| December, 2028 | $8.7902 | $8.0902 | $9.7284 | +9.19% |
Aurinia Pharmaceuticals Inc Stock (AUPH) Price Forecast for 2029
The 2029 price forecast for Aurinia Pharmaceuticals Inc Stock (AUPH) is $7.6952 on average, with a high prediction of $11.54 and a low estimate of $3.848. This represents an -4.41% decrease from the previous price of $8.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.69 | $8.8207 | $11.54 | +32.83% |
| February, 2029 | $8.2754 | $8.0154 | $10.63 | +2.80% |
| March, 2029 | $7.9577 | $7.9477 | $9.3577 | -1.15% |
| April, 2029 | $6.64 | $6.0994 | $8.1033 | -17.52% |
| May, 2029 | $6.8629 | $6.0624 | $7.6129 | -14.75% |
| June, 2029 | $8.1852 | $6.6235 | $9.1741 | +1.68% |
| July, 2029 | $8.1175 | $7.4014 | $8.867 | +0.84% |
| August, 2029 | $6.6704 | $6.6593 | $8.5587 | -17.14% |
| September, 2029 | $5.0828 | $4.4828 | $7.6322 | -36.86% |
| October, 2029 | $4.1057 | $4.0757 | $5.2533 | -49.00% |
| November, 2029 | $4.128 | $3.848 | $4.5468 | -48.72% |
| December, 2029 | $4.17 | $3.9086 | $4.4497 | -48.20% |
Aurinia Pharmaceuticals Inc Stock (AUPH) Price Forecast for 2030
Aurinia Pharmaceuticals Inc Stock (AUPH) is expected to reach an average price of $10.70 in 2030, with a high forecast of $19.91 and a low forecast of $1.4878. This signifies an +32.92% surge from the last price of $8.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.1058 | $3.9412 | $4.7235 | -49.00% |
| February, 2030 | $4.4205 | $4.027 | $4.6193 | -45.09% |
| March, 2030 | $4.2301 | $4.0137 | $4.4316 | -47.45% |
| April, 2030 | $3.6397 | $3.3262 | $4.1762 | -54.79% |
| May, 2030 | $3.3105 | $3.2355 | $4.5632 | -58.88% |
| June, 2030 | $2.8901 | $1.4878 | $3.389 | -64.10% |
| July, 2030 | $4.0879 | $2.6313 | $4.3459 | -49.22% |
| August, 2030 | $17.58 | $3.7671 | $18.01 | +118.39% |
| September, 2030 | $18.24 | $17.50 | $19.91 | +126.52% |
| October, 2030 | $16.67 | $15.17 | $18.36 | +107.03% |
| November, 2030 | $11.16 | $9.9956 | $18.44 | +38.58% |
| December, 2030 | $12.42 | $7.8268 | $13.11 | +54.23% |
1.23%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):